Get the real deal on beauty treatments—real doctors, real reviews, and real photos with real results.Here's how we earn your trust.
Hello,Topical Elidel (pimecrolimus) is an immunomodulator typically used to treat inflammatory skin conditions like eczema. While it isn’t a standard treatment for alopecia areata, which is an autoimmune condition, there is some theoretical potential for it to help by modulating the immune response around hair follicles. However, its efficacy for alopecia areata has not been well-established in clinical studies.Corticosteroids, minoxidil, and other immunotherapies are more commonly used and have a stronger evidence base for treating alopecia areata. I recommend consulting with a hair loss specialist to determine the most effective treatment plan for your specific case.Best regards,Dr. Marco Barusco
Elidel has been used alone or in combination with Retin A to treat Alopecia Areata. I works in some cases but like all other treatments for this condition it works for some but not in others. It s kind of a trial and error situation like many other skin conditions. if something works stick with it if nit try something else.
I would definitely see your dermatologist. Of course it could be progression of the hair loss being treated by finasteride but there are other conditions that could cause this as well. A medication change or addition may be needed. But the faster you get a dignosis and start treatment the better.
Oral minoxidil works by widening blood vessels, increasing blood flow to hair follicles, and stimulating hair growth. On the other hand, Topical minoxidil is specifically formulated for hair loss and is applied directly to the scalp. It works by increasing blood flow to the hair follicles,...
For most small, coin-shaped, patches of alopecia areata, 1-2 visits to the doctor are sufficient to trigger growth. Not all patients experience growth but 90 % or more do. Patients with many patches or patients with larger amounts of hair loss may not benefit from steroid injections. Treatment...
